CSB 2.002 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register April 2023 No. 808, eff. 4-17-23; correction made under s.
35.17, Stats.,
Register April 2023 No. 808.
CSB 2.003
CSB 2.003
Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.
961.14 (5) (aa) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ab) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one).
(ac) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ad) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
(ae) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).
CSB 2.003 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register September 2023 No. 813, eff. 9-25-23; correction in (2) made under s.
35.17, Stats.,
Register September 2023 No. 813.
961.20 (2) (r) Zuranolone.
CSB 2.004 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register February 2024 No. 818, eff. 2-5-24; correction in numbering of CSB 2.004 made under s.
13.92 (4) (b) 1., Stats.,
Register February 2024 No. 818.
CSB 2.005
CSB 2.005 Addition of 9 Fentanyl Related Substances to Schedule I.
961.14 (2) (nd) 3m. Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
10m. 2',5'-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
CSB 2.005 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register February 2024 No. 818, eff. 2-5-24.
CSB 2.006
CSB 2.006 Adding 5 Synthetic Cannabinoids to Schedule I.
961.14 (4) (tb) 54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.
55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.
56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.
57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.
58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.
CSB 2.006 History
History:
cr. Affirmative action order under s.
961.11 (4), Stats.,
Register February 2024 No. 818, eff. 2-5-24.
CSB 2.007
CSB 2.007 Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.
961.14 (4) (tb) 32m. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide, commonly known as ADB-BUTINACA.
961.14 (7) (L) 2m. 3-methylmethcathinone or 2-(methylamino)-1-(3-methylphenyl)propan-1-one, commonly known as 3-MMC.
36m. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one, commonly known as alpha-PiHP.
CSB 2.007 History
History:
cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 6-17-24; correction in (title) made under s. 13.92 (4) (b) 2., Stats., Register June 2024 No. 822.
961.14 (2) (qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
CSB 2.008 History
History:
cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 5-20-24; correction made under s. 35.17, Stats., Register June 2024 No. 822.
APPENDIX
CSB 2.008 Note
Note:
This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss.
CSB 2.01 to
2.99.
CSB 2.008 Note
CSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s.
161.16, Stats., schedule II in sub. (6) which subsection is hereby created.
CSB 2.008 History
History:
Cr.
Register, June, 1973, No. 210, eff. 7-1-73.
CSB 2.008 Note
CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The
substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s.
161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:
CSB 2.008 Note
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.008 Note
(a) Benzphetamine
CSB 2.008 Note
(b) Chlorphentermine
CSB 2.008 Note
(c) Clortermine
CSB 2.008 Note
(d) Mazindol
CSB 2.008 Note
(e) Phendimetrazine
CSB 2.008 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.008 Note
CSB 2.03 Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to s.
161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:
CSB 2.008 Note
(2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:
CSB 2.008 Note
(a) Fenfluramine:
CSB 2.008 History
History:
Cr.
Register, October, 1973, No. 214, eff. 11-1-73.
CSB 2.008 Note
CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection
(7) of s.
161.16, Stats., schedule II is hereby created to read as follows:
CSB 2.008 Note
(7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
CSB 2.008 Note
(a) Amobarbital
CSB 2.008 Note
(b) Pentobarbital
CSB 2.008 Note
(c) Secobarbital
CSB 2.008 Note
(2) Paragraphs (m) and (n) of sub. (3), s.
161.18, Stats., schedule III, are hereby created to read as follows:
CSB 2.008 Note
(m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CSB 2.008 Note
(n) Unless excepted under federal regulations, any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the federal food and drug administration for marketing only as a suppository.
CSB 2.008 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.008 Note
CSB 2.05 Addition of drotebanol to schedule I. The substance known as drotebanol is hereby added to s.
161.14, Stats., schedule I in sub. (3), par. (hm), which paragraph is created to read:
CSB 2.008 Note
(hm) Drotebanol;
CSB 2.008 History
History:
Cr.
Register, July, 1974, No. 223, eff. 8-1-74.
CSB 2.008 Note
CSB 2.06 Addition of pentazocine to schedule III. Subsection
(4m) of s.
161.18, Stats., schedule III is hereby created to read as follows:
CSB 2.008 Note
(4m) Pentazocine.
CSB 2.008 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.008 Note
CSB 2.07 Transfer of hydrochloride form of etorphine from schedule I to schedule II. (1) Subsection
(3) (intro.) of s.
161.14, Stats., schedule I is amended to read:
CSB 2.008 Note
(3) Unless specifically excepted or listed in another schedule, any of the following opium derivatives, their salts, isomers and salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
CSB 2.008 Note
(2) Paragraph (em) of sub. (3), s.
161.16, Stats., schedule II, is hereby created to read:
CSB 2.008 Note
(em) Etorphine hydrochloride;
CSB 2.008 History
History:
Cr.
Register, August, 1974, No. 224, eff. 9-1-74.
CSB 2.008 Note
CSB 2.08 Addition of poppy straw to schedule II, addition of pemoline and mebutamate to schedule IV. (1) Paragraph (d) of sub. (2), s.
161.16, Stats., schedule II is hereby created to read:
CSB 2.008 Note
(d) Concentrate of poppy straw (the crude extract of Poppy Straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy).
CSB 2.008 Note
(2) Paragraph
(n) of sub.
(2) of s.
161.20, Stats., schedule IV is hereby created to read:
CSB 2.008 Note
(n) Mebutamate